Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of tDCS to Enhance Virtual Reality Exposure Therapy Response in Acrophobia: A Randomized Controlled Trial

NCT05841329 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.

NCT NCT05841329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05841329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of tDCS to Enhance Virtual Reality Exposure Therapy Response in Acrophobia: A Randomized Controlled Trial
Lead sponsor
Shanghai Mental Health Center
Phase
Not applicable
Overall status
Completed
Start date
August 6, 2020
Completion date
July 15, 2021
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acrophobia, transcranial direct current stimulation